Engineering the Future of Regenerative Systems.
GenRey is a sovereign-scale biotechnology integrating regenerative science, translational medicine, artificial intelligence, and global infrastructure.
Why GenRey Exists
GenRey is building a single regenerative medicine global platform with an aim to repair, restore and rejuvenate the health to keep the individuals healthy, active and functional.
Multi-Disciplinary Sovereign Platform
Multi disciplinary, sovereign and high impactful regenerative medicine platform with a global vision.
GenRey is building a single global platform for regenerative medicine engineered to repair, restore, and rejuvenate the human body, extending the years people live in full health, strength, and function.
Multiple Products in a Single Regenerative Systems Platform.
One integrated architecture. Every layer of medicine: discovery, translation, manufacturing, deployment. Connected.
AI integration
Genomics, proteomics, and computational biology embedded across discovery, clinical prediction, and omics analysis.
Regenerative Medicine
Cellular repair, tissue regeneration, and organ biofabrication translated into deployable clinical therapeutics.
Translational Research
Bench-to-bedside pathways that move discoveries through validation, trials, and regulatory approval at speed.
Commercialization Engine
IP, regulatory strategy, and go-to-market infrastructure architected from day one. Not bolted on after launch.
Sovereign Collaboration
US–GCC dual-hub architecture aligned with Vision 2030 and national life-sciences priorities.
Manufacturing
Scalable cGMP-grade production engineered for regenerative therapeutics at population scale.
Clinical Deployment
Hospital, clinic, and physician-network channels designed to deliver therapies where care actually happens.
Ecosystem Architecture
Research, capital, talent, and policy partners coordinated into a single regenerative biotech corridor.
Six Strategic Initiatives. One Connected Platform.
Each initiative advances a distinct frontier of regenerative science, unified through GenRey's integrated infrastructure
Hair
Regeneration
iREY™, a multimodal platform combining a handheld delivery device with a proprietary bioactive serum ecosystem. The near-term commercialization flagship, targeting a global hair restoration market exceeding $20B.
Built for Global Strategic Alignment
GenRey is structured as a sovereign-scale platform, designed for institutional alignment with the Kingdom of Saudi Arabia, the United Arab Emirates, and Qatar, anchored in Vision 2030 and the regional ambition to lead the next era of life sciences.
A Sovereign-Scale Platform
GenRey's architecture is purpose-built to advance regional priorities: domestic biotechnology capability, intellectual property co-ownership, and clinical workforce development, anchoring a permanent regional innovation corridor in regenerative medicine. We do not approach GCC participation as a market entry. We approach it as institutional partnership in the construction of long-term scientific and economic infrastructure.
Vision 2030 Alignment
Direct contribution to the strategic ambitions of the Kingdom of Saudi Arabia and the broader GCC: life sciences leadership, knowledge economy development, and global scientific positioning.
Healthcare Innovation
Advancing regenerative medicine, precision therapeutics, and clinical translation infrastructure that compound into measurable improvements in healthcare delivery and patient outcomes across the region.
Scientific Infrastructure
Establishing manufacturing facilities, research collaboration networks, and institutional partnerships that anchor sovereign biotechnology capability within partner nations.
Talent Development
Clinical training, scientific workforce development, and institutional research programs designed to build a highly skilled domestic life sciences workforce over the long term.
Economic Diversification
Co-ownership of globally relevant intellectual property, domestic manufacturing and commercialization, and establishment of new high-value knowledge industries, diversifying the regional economic base.
Sustainable Biotech Ecosystems
Building permanent institutional and industrial infrastructure for regenerative medicine: research, manufacturing, clinical deployment, and commercial translation. Engineered to last beyond any single program or initiative.
Leadership & Scientific Advisory
Led by physician-scientists, researchers, and biotechnology operators working across regenerative medicine, drug discovery, tissue engineering, and advanced healthcare innovation.
Executive Leadership Team
The Executive Leadership Team guides GenRey's scientific vision, operational execution, strategic partnerships, commercialization pathways, and long-term institutional growth.
Guiding GenRey's scientific vision, operational execution, strategic partnerships, and long-term institutional growth.
Dr. Jerry Lorren Dominic, MD
Co-Founder, President & Chief Executive Officer
Directing operational execution, infrastructure scaling, commercial pathways, and strategic partner deployment.
Mohammad Yasar Qureshi
Co-Founder & Chief Operating Officer
Leading regenerative science pipelines, translational clinical validation, and scientific advisory governance.
Dr. Sudheer Kumar Ravuri, PhD
Chief Scientific Officer & Founding Scientific Advisor — Chairman, Board of Directors
Scientific Advisory Committee
Guided by world-class executives, researchers, and clinical leaders in biotechnology and sovereign medicine.
Advisory guidance across clinical strategy, regenerative medicine, and industry relations.
Dr. Daniel A. Romanelli, MD
Senior Advisor
Advisory guidance across regenerative medicine and clinical development.
Dr. Moses Raj, MD
Scientific Advisory Committee Member
Advisory guidance across innovation and technology development.
Dr. Aaron H. Wolfson, MD
Scientific Advisory Committee Member
Advisory guidance across clinical development and platform strategy.
Dr. Patricia Byers, MD
Scientific Advisory Committee Member
Advisory guidance across clinical strategy, biotechnology innovation, and platform deployment.
Dr. Asim Elahi, MD
Scientific Advisory Committee Member
Program Directors
GenRey's Program Directors support the development, coordination, and advancement of key scientific, clinical, and operational programs across the platform.
Program coordination, operational management, and cross-functional platform execution
Kaushik Sreerama Reddy
Program Management Officer
Oncology research and scientific strategy advancing GenRey's clinical translation programs
Dr. Matthew Witkin, MD
Program Director
Head and neck surgery, facial reconstruction, and regenerative biotechnology translation
Dr. Adam Bender-Heine, MD
Program Director
Program coordination and scientific strategy advancing GenRey's platform execution.
Dr. Jeffrey James Skubic, DO
Program Director
Program coordination and scientific strategy advancing GenRey's platform execution.
Dr. Paul Anthony Berry, MD
Program Director
Program coordination and scientific strategy advancing GenRey's platform execution.
Dr. Mohammad Waqas Khan, MD
Program Director
Program coordination and scientific strategy advancing GenRey's platform execution.
Dr. Bindiya Sachdev, PhD
Program Director
Program coordination and scientific strategy advancing GenRey's platform execution.
Dr. Swathi Godugu, MD
Program Director
Program coordination and scientific strategy advancing GenRey's platform execution.
DR. Eevee Zhou, MD
Program Director
Digital & IT Operations
Manages the organization’s digital infrastructure and online presence. This role oversees website performance, manages IT systems and solutions, and drives digital engagement through strategic social media communication.
A Digital Communications shapes and manages an organization's online presence to boost brand visibility and engagement.
Er. Mintu Simson, B.E CSE
Digital Communications Lead
Common Questions
Partner With GenRey
Join leading life-sciences institutions and sovereign entities in building the next generation of translational healthcare infrastructure.